Sign In
Get Clay Free →

Suggestions

    Jan Kirsten

    President & Managing Director at Merck Italia - Advisor - Angel Investing

    Jan Kirsten is the President & Managing Director of Merck Italia, a role he has held since July 2021.1 He is a highly experienced business leader with a strong background in healthcare and biotechnology.

    Professional Background:

    • Previously served as Senior Vice President and Global Head of the Fertility Franchise at Merck12
    • Holds a doctorate in Business Management and a master's in Business Research from Munich School of Management
    • Has a Master of Science in Molecular Biology from Julius-Maximilians-University in Würzburg, Germany1

    Career Highlights:

    • Has been with Merck for over 13 years, holding roles of increasing responsibility1
    • Transitioned from leading the global fertility franchise to managing Merck's Italian operations2
    • Responsible for over 1,200 employees across four sites in Italy3

    Leadership Philosophy: Kirsten emphasizes cross-cultural understanding, innovation, and developing talent. He believes in bringing fresh perspectives to local markets and fostering organizational agility.2 His background in both biology and business enables him to make strategic decisions across different domains.3

    Current Role: At Merck Italia, he oversees the company's strategic, operational, financial, and legal aspects across all functions and therapeutic areas, with a focus on oncology, neurology, cardiometabolic care, and fertility.2

    Highlights

    Jan Kirsten, Managing Director & President - Merck Italia
    Jan Kirsten, Managing Director & President - Merck Italia
    Jun 7 · merckgroup.com
    Jan Kirsten nuovo GM di Merck in Italia
    Apr 1 · xing.com
    Dr. Jan Kirsten - President & Managing Director at Merck Italy - XING

    Related Questions

    Quali sono stati i principali progetti di Jan Kirsten alla Merck?
    Come ha influenzato Jan Kirsten il business della fertilità alla Merck?
    Quali sono le competenze principali di Jan Kirsten?
    In che modo Jan Kirsten ha contribuito alla trasformazione di Merck?
    Quali sono le future prospettive per il business Healthcare di Merck in Italia?